This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Sementis Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations of Liang Liu in Viral Vector Manufacture
Introduction
Liang Liu is an accomplished inventor based in South Australia, AU. He has made significant contributions to the field of biotechnology, particularly in the development of viral vector manufacturing techniques. His innovative work has the potential to advance therapeutic applications and improve the efficiency of viral propagation.
Latest Patents
Liang Liu holds a patent for a method related to viral vector manufacture. This invention involves a modified mammalian cell in which the genome is altered to include a sequence encoding CP77 under the control of a promoter. This modification allows the cell line to sustain the propagation of a poxvirus that is less able or unable to propagate in unmodified cells. This advancement could have important implications for vaccine development and gene therapy.
Career Highlights
Liang Liu is currently associated with Sementis Limited, a company focused on innovative vaccine development. His work at Sementis Limited has positioned him as a key player in the biotechnology sector. With a patent portfolio that includes 1 patent, he continues to push the boundaries of what is possible in viral vector technology.
Collaborations
Liang Liu collaborates with various professionals in the field, including his coworker Paul Michael Howley. Their combined expertise contributes to the ongoing research and development efforts at Sementis Limited.
Conclusion
Liang Liu's contributions to viral vector manufacture exemplify the innovative spirit of modern biotechnology. His work not only enhances our understanding of viral propagation but also paves the way for future advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile